Emmanuela E Ambrose on stroke prevention in children with sickle cell disease

<p>Dr Emmanuela E Ambrose tells us about the SPHERE trial on hydroxyurea dose escalation for primary stroke prevention in children with sickle cell disease in Tanzania<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(22)00405-7/fulltext'>Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE)</a></p>